CLINICAL TRIALS PROFILE FOR TOBREX
✉ Email this page to a colleague
505(b)(2) Clinical Trials for TOBREX
Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|---|
New Formulation | NCT00404937 ↗ | Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle | Withdrawn | Alcon Research | Phase 3 | 2006-12-01 | The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation |
>Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for TOBREX
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00404937 ↗ | Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle | Withdrawn | Alcon Research | Phase 3 | 2006-12-01 | The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation |
NCT00695435 ↗ | Tobramycin Tear Concentrations | Completed | Alcon Research | Phase 1 | 2008-06-01 | To evaluate the Tobramycin tear concentration values of TOBRADEX® Ophthalmic Suspension, Tobramycin 0.3% / Dexamethasone 0.05% Ophthalmic Suspension versus TOBREX® Ophthalmic Solution in normal volunteers. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TOBREX
Condition Name
Clinical Trial Locations for TOBREX
Trials by Country
Clinical Trial Progress for TOBREX
Clinical Trial Phase
Clinical Trial Sponsors for TOBREX
Sponsor Name